Research on Technological Innovation and Clinical Application of Intelligent Non-Invasive Blood Glucose Monitoring System: A Case Study of “Hengtang Zhihang”
Download PDF

Keywords

Diabetes
Blood glucose monitoring
Third-generation glucose sensing technology
Intelligent medical system
Non-invasive monitoring

DOI

10.26689/ijgpn.v3iSpecial.14068

Submitted : 2026-02-08
Accepted : 2026-02-23
Published : 2026-03-10

Abstract

With the global prevalence of diabetes escalating, traditional blood glucose monitoring technologies are constrained by inadequate precision, discontinuous monitoring, and inefficient clinical collaboration. This paper focuses on the “Hengtang Zhihang” intelligent non-invasive blood glucose management system, which is developed based on China’s pioneering third-generation glucose sensing technology. It systematically analyzes the system’s integrated solution covering hardware, software, and clinical services, and comprehensively compares its advantages over traditional methods such as capillary blood glucose monitoring and conventional continuous glucose monitoring. Clinical application data from a tertiary hospital in Shanghai verifies that the system significantly reduces diabetes-related complications and improves the operational efficiency of medical institutions. Additionally, this paper explores the system’s market-oriented operation path and technological iteration direction. The research findings provide valuable references for promoting the innovation and development of diabetes monitoring technology and advancing the localization of high-end medical devices in China.

References

International Diabetes Federation (IDF), 2021, IDF Diabetes Atlas (10th Edition), viewed December 20, 2023, https://www.diabetesatlas.org

Chinese Society of Endocrinology and Metabolism, 2021, Guidelines for the Prevention and Treatment of Type 2 Diabetes in China (2020 Edition). Chinese Journal of Endocrinology and Metabolism, 38(5): 401–405.

Song T, Liu BL, 2023, Enhanced Heat Transfer by Medical Gauze for Cell Vitrification. CryoLetters, 44(5): 258–262.

Shanghai Daoxiang Medical System Co., Ltd., 2022, Cryoablation Needle and System for Tumor Treatment (China Patent No. ZL202111329707.3), National Intellectual Property Administration, PRC, viewed December 20, 2023, https://pss-system.cponline.cnipa.gov.cn

Shanghai Daoxiang Medical System Co., Ltd., 2022, A Multi-Needle Cryoablation Device and Its Control Method (China Patent No. ZL202111329723.2), National Intellectual Property Administration, PRC, viewed December 20, 2023, https://pss-system.cponline.cnipa.gov.cn